FDA inspection
Sentry Biopharma Services, Inc.: FDA inspection ending Jun 29, 2021
FDA inspection 1151136 · No Action Indicated (NAI) · Indianapolis, IN
Key facts
| Inspection ID | 1151136 |
|---|---|
| Firm | Sentry Biopharma Services, Inc. |
| FEI number | 3007066137 |
| Address | 4605 Decatur Blvd |
| City | Indianapolis |
| State | IN |
| ZIP | 46241 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | Jun 29, 2021 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data